Publication: The efficacy and drug survival of the biosimilar infliximab (ct-p13) compared to the original reference infliximab in inflammatory rheumatic diseases; Results from the turkbio registry
Date
Authors
Dalkılıç, Ediz
Authors
Uslu, Sadettin
Can, Gerçek
Şenel, Soner
İnanç, Nevsun
Akars, Servet
Kocaer, Sinem Burcu
Birlik, Merih
Capar, Sedat
Akkoç, Nurullah
Önen, Fatoş
Advisor
Language
Type
Publisher:
Wiley
Journal Title
Journal ISSN
Volume Title
Abstract
Description
Source:
Keywords:
Keywords
Rheumatology
Citation
Uslu, S. vd. (2018). ''The efficacy and drug survival of the biosimilar infliximab (ct-p13) compared to the original reference infliximab in inflammatory rheumatic diseases; Results from the turkbio registry''. Arthritis & Rheumatology, 70(Supplement 9).